Doc knocks DTC diagnostic ads

Share this article:

Writing in the December issue of Obstetrics & Gynecology, Dr. Erin Tracy said DTC ads for genetic tests are virtually unregulated and tests are costly and oft-misunderstood by consumers. Referring to the BracAnalysis ad campaign by Myriad Genetics, Tracy said: “Some patients with no risk factors for breast cancer come in and request the test for BRCA-1 and BRCA-2 mutations. The ads are compelling and they're emotionally driven. I end up spending time discussing why a particular test being advertised is not appropriate when I should be addressing important issues such as eating a healthy diet or smoking cessation.” 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.